Loss of substantia nigra dopaminergic neurons results in Parkinson disease (PD). Degenerative PD usually presents in the seventh decade whereas genetic disorders, including mutations in PARK2, predispose to early onset PD. PARK2 encodes the parkin E3 ubiquitin ligase which confers pleotropic effects on mitochondrial and cellular fidelity and as a mediator of endoplasmic reticulum (ER) stress signaling. Although the majority of studies investigating ameliorative effects of parkin focus on dopaminergic neurons we found that astrocytes are enriched with parkin. Furthermore, astrocytes deficient in parkin display stress-induced elevation of nucleotideoligomerization domain receptor 2 (NOD2), a cytosolic receptor integrating ER stress and inflammation. Given the neurotropic and immunomodulatory role of astrocytes we reasoned that parkin may regulate astrocyte ER stress and inflammation to control neuronal homeostasis. We show that, in response to ER stress, parkin knockdown astrocytes exhibit exaggerated ER stress, JNK activation and cytokine release, and reduced neurotropic factor expression. In coculture studied we demonstrate that dopaminergic SHSY5Y cells and primary neurons with the presence of parkin depleted astrocytes are more susceptible to ER stress and inflammation-induced apoptosis than wildtype astrocytes. Parkin interacted with, ubiquitylated and diminished NOD2 levels. Additionally, the genetic induction of parkin ameliorated inflammation in NOD2 expressing cells and knockdown of NOD2 in astrocytes suppressed inflammatory defects in parkin deficient astrocytes and concurrently blunted neuronal apoptosis. Collectively these data identify a role for parkin in modulating NOD2 as a regulatory node in astrocytic control of neuronal homeostasis.
knockout (KO) mice (Frank-Cannon et al., 2008) and neuroinflammation is increasingly recognized as a contributory factor in PD neurodegeneration (Hirsch, Vyas, & Hunot, 2012; Tansey & Goldberg, 2010) , a question arising is whether parkin has a role as a glial 'neurotropic' mediator to confer protection against neuronal cell degeneration.
The predominant glial cells within the substantia nigra pars compacta include microglia and astrocytes. Microglia are the resident 'macrophages' in the brain, possess neuronal repair and maintenance functions, and play a role in the innate immune response (Kofler & Wiley, 2011; Ransohoff, 2016) . Astrocytes are critical supporters of neuronal integrity and homeostasis and function to control processes including antioxidant protection, glutamate clearance and signaling release through gliotransmitters, cytokines and metabolic enzymes (Hamby & Sofroniew, 2010; Mamczur et al., 2015; Volterra & Meldolesi, 2005) .
Concurrently, mechanistic pathways are being identified that link ER stress to sterile inflammation (Garg et al., 2012; Keestra-Gounder et al., 2016) . Given that LPS augments neuronal injury in Parkin KO mice (Frank-Cannon et al., 2008) and that parkin expression is higher in astrocytes as compared with microglia, we have begun to explore whether astrocytic ER stress and inflammation work in concert, in a parkin-dependent manner to modulate neuronal homeostasis. In this study, we find that parkin plays a critical role in the maintenance of astrocyte neurotropic function in response to ER stress and inflammation. This was shown in ER stressed primary coculture studies where the restricted genetic disruption of parkin in astrocytes resulted in greater apoptotic cell death in neurons compared with their coculture with wildtype (WT) astrocytes. Consistent with this phenotype, parkin KO astrocytes exhibited exaggerated ER stress defects and had decreased expression of neurotropic factors compared with the WT astrocytes. Additionally, we identify nucleotide-oligomerization domain receptor 2 (NOD2) as a parkin substrate and show that parkin mediates NOD2 ubiqutylation and degradation. This proteasomal degradation of NOD2 is critical for the maintainance of normal astrocyte neurotropic function. Collectively these data identify a role for parkin in modulating NOD2 as a regulatory node in astrocytic control of neuronal homeostasis and support an emerging concept that the neuroprotective effects of parkin may be mediated, in part, through paracrine effects of parkin in glial cells.
| MATERIALS AND METHODS

| Animals
Parkin KO (B6.129S4-Park2-tm1shn/J) and WT (c57bl/6) mice were obtained from the Jackson Laboratory and backcrossed (>10 generations) into the C57BL/6 J strain. All animal procedures were conducted using an animal protocol approved by the National Heart Lung, and Blood Institute (NHLBI) Animal Care and Use Committee.
| Cell cultures and enzyme linked immunosorbent assay (ELISA)
HEK293T, HeLa and Neu7 astrocyte (Fidler et al., 1999 ) cell lines were used in parkin overexpression studies. Coimmunoprecipitation was performed in HEK293T cell extracts. Primary astrocyte cultures were prepared from postnatal littermates (age range: Day 2 [P2]-Day 4 [P4]) as described previously in Yu, Wang, Katagiri, and Geller (2012) ). Briefly, cortical tissues were dissected from the brain and meninges were removed. Tissues were mechanically dissociated with Trypsin and plated on T75 flasks (cortical tissues of two littermates/ flask). The cells were cultured for 14-16 days in Dulbecco Modified Eagle Medium (DMEM) (Gibco) supplemented with 10% fetal bovine serum (FBS`, Gibco) and antibiotic/antimycotic solution (Gibco), in a 37 C, 5% CO 2 incubator. Upon confluency, the plates were shaken on a rotor for 2 hr to remove microglia. Astrocytes were dissociated with TrypLE (Thermofisher) and transferred to 6-or 24-well plates. Primary cortical neurons from the brain of WT embryonic (E18.5) mice were cultured as described (Foo et al., 2011; Tilve, Difato, & Chieregatti, 2015) . Briefly, cortical tissues were freed from meninges and digested with 0.25% Trypsin. Primary neurons were plated on a confluent layer of primary astrocytes of either genotype. The cocultures were incubated for 7 days in Neurobasal media supplemented with 2% B27
(Gibco), 10% DMEM, 1% FBS, and 1% penicillin/streptomycin (Gibco).
HEK293T, HeLa, Neu7, and SHSY5Y cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin (Gibco).
For ELISA, astrocytes were exposed to LPS (10 ng/mL, Enzo Life Sciences) alone or combination of LPS (10 ng/mL) and thapsigargin (TG, 0.5-1 μg/mL) for 12-16 hrs. Tumor necrosis factor alpha (TNFα) (R&D systems) and interleukin 6 (IL6) (R&D systems) ELISA was performed on cell culture media following manufacturer's protocol. The cytokine released was normalized to the protein concentration of respective cell sample and was reported as fold change compared with the WT or control as indicated.
| Plasmids, lentiviruses, and transfection
NOD2-HA in pcDNA3 plasmid was a gift from Dr. Gabriel Nunez lab, Univeristy of Michigan, Ann Arbor, MI. Parkin-Flag construct generated previously (Han et al., 2017) . NOD2 cDNA from the pcDNA3 plasmid was subcloned into a p3xFlag (Sigma) vector using BamHI and KpnI restriction enzymes. Parkin cDNA was subcloned into the pLVX (Clontech) lentivirus expression plasmid. Parkin shRNA (TRCN0000283 and TRCN0000284) and NOD2 shRNA (TRCN0068813, TRCN0068814, and TRCN0362622) lentivirus plasmids were obtained from Sigma. Lentiviruses were amplified by transfecting HEK293T cells with transfer plasmids, pMDG.2 (Addgene no. 12259) and psPax2 (Addgene no. 12260).
The lentivirus from the cell culture media was filtered using 45 μm filter and concentrated by ultracentrifugation. Lentiviral transduction was performed in the presence of polybrene and the media was changed 24 hr post transduction. Transient transfection was performed on cells at approximately 80% confluency using PolyJet (Signagen).
| Immunoprecipitation and immunoblot analysis
Total proteins from cells were extracted using RIPA buffer (50 mM 
| Cocultures and survival assays
Cocultures of dopaminergic SHSY5Y neurons and mouse primary astrocytes were performed in 0.4-μm transwell dishes (Sigma). The astrocytes of either genotype were plated in the transwell and cocultured with SHSY5Y cells where the media and the secretory components were shared between the two cell types. The cocultures were then exposed to 6-hydroxydopamine (6-OHDA, 50 μM), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, 100 μM), TG (0.05 μg/ mL) or combination with TG and LPS (5 ng/mL). In isolated SHSH5Y
cultures the doses were adjusted and the dose of 6-OHDA used was 5 μM and the toxic metabolite of MPTP, that is, MPP + was used (10 μM). WT primary cortical neurons were isolated and plated on a confluent bed of either parkin WT or KO astrocytes. The astrocyteneuron cocultures were incubated in neurobasal media for 5 days (Foo et al., 2011 3 | RESULTS
| Astrocyte restricted depletion of parkin augments neuronal ER stress and inflammation-induce injury
To assess This result is consistent with prior data suggesting that parkin reduces neurotoxicity (Bian et al., 2012; Jiang, Ren, Zhao, & Feng, 2004) .
To explore our hypothesis pertaining to a possible parkin role in response to ER stress and inflammation these cocultured cells were then exposed to TG (as a trigger of ER stress) in the presence or absence of LPS. When SHSY5Y and astrocyte cocultures were Figure S1d ). Of note, to exclude the potential for differential immunomodulatory effects between primary neurons and astrocytes isolated from the same versus different mice, primary cortical neurons and astrocytes were not harvested from the same mice.
| Lack of parkin alters expression level of neurotropic factor and ER stress genes in astrocytes
The impaired neuroprotection conferred by parkin KO astrocytes is likely due to the alteration in neurotropic signaling in these cells. To address this possibility, targeted gene expression profiling using qRT-PCR was performed in primary astrocytes in response to the ER stressor TG. Consistent with the phenotype described above, transcripts encoding canonical astrocyte neurotropic growth factors including BDNFs and GDNFs were found to be expressed at significantly reduced level in parkin KO astrocytes after exposure to TG (Figure 2a) . In rescue experiments, BDNF and GDNF mRNA levels were restored when parkin KO astrocytes were transduced with parkin cDNA lentivirus (Figure 2b ), and the introduction of BDNF into the culture media abolished LDH release after exposure to TG in both parkin replete and deficient SHSY5Y cells (Supporting Information Figure S2a ). Additionally, canonical ER stress regulated genes including the expression of spliced Xbp1, ATF6, ATF4, CHOP, and Ccl2 were expressed at significantly higher levels in parkin KO astrocytes in response to TG (Figure 2c ). The increased ER stress encoding gene transcript levels in parkin KO astrocytes was similarly rescued following reconstitution of parkin in these KO astrocytes (Figure 2d ). 
| NOD2 depletion rescues inflammatory/ neurotropic defects in parkin KO astrocytes
To further evaluate the effect of the parkin-NOD2 regulatory axis on astrocyte function, NOD2 was depleted by shRNA in astrocytes. WT and parkin KO astrocytes were transduced with control or various NOD2 shRNA lentiviruses and then exposed to endotoxin (LPS) and TG. Parkin KO astrocytes transduced with control shRNA lentivirus displayed significantly greater secretion of inflammatory cytokines, TNFα and IL6 compared with WT astrocytes (Figure 5a,b) . Moreover and consistent with our hypothesis, transduction with NOD2 shRNA lentiviruses reduced cytokines secretion from astrocytes of both . Statistical difference was assessed by student's t test or two-way ANOVA followed by multiple comparisons tests. *p < .05, compared with the corresponding controls. N.S = not significant. All experiments were repeated ≥3 times that parkin is implicated in the modulation of ER stress protein folding (Imai et al., 2000; Imai et al., 2001; Imai et al., 2002) . Additionally, mutations in parkin and its genetic depletion activate CHOP-mediated ER stress triggered apoptosis (Han et al., 2017) and the depletion of CHOP protects against neurotoxin-induced substantia nigra dopaminergic neuron cell death (Silva et al., 2005) . Moreover, emerging data support the integration of ER stress signaling with immune cell activation (Keestra-Gounder et al., 2016; Martinon, Chen, Lee, & Glimcher, 2010; Shenderov et al., 2014) . Studies find that ER stress activates innate immune signaling (Deng et al., 2004; Wu et al., 2004) and conversely that the activation of innate immune receptors amplify inflammation via ER stress signaling (Martinon et al., 2010) . Taken together these findings implicate a coordinate and amalgamated interaction between ER stress and inflammatory signaling pathways.
The canonical mediators linking these two stress responsive pathways include ROS, NF-κB signaling and JNK activation (Zhang & Kaufman, 2008) . More recently the cytosolic NOD1/2 sensors, which traditionally respond to bacterial peptidoglycan fragments, were found to respond to ER stress to initiate inflammatory signaling (KeestraGounder et al., 2016) . Interestingly, this ER stress-induced NOD signaling was independent of peptidoglycans, but required the canonical TNF receptor-associated factor 2 (TRAF2) signaling pathway for immune activation (Keestra-Gounder et al., 2016) . Our study contributes to the further characterization of the role of parkin in the control of ER stress and in the integration of ER stress signaling with inflammatory signaling.
Although, the role of NOD signaling in Parkin has not been extensively explored, an association with polymorphisms of NOD2 could potentially be associated with sporadic PD (Bialecka et al., 2007; Ma et al., 2013) , although this finding has also been questioned (Appenzeller et al., 2012) . Another potential link between NOD2 with increased susceptibility to PD could hypothetically be through the multifunctional protein kinase LRRK2. Mutations in LRKK2 is a well characterized causative mutations linked to EOPD (Klein & Schlossmacher, 2006) and it has recently been recognized that the inflammatory effects of NOD2 are mediated by LRRK2 (Yan & Liu, 2017; Zhang et al., 2015) . This regulatory link does not appear to have been directly explored in the pathogenesis of PD, but warrants further exploration.
Parkin, through the specificity of the lysine residue and number of covalent ubiquitin modifications, confers either nondegrading signaling effects or promote proteasome-dependent degradation of substrate proteins (Abumrad & Moore, 2011) . This spectrum of substrate modifications is evident on inflammatory mediators where parkindependent ubiquitylation stabilizes the CD36 scavenger receptor (Kim et al., 2011) and NFκB essential modulator (Muller-Rischart et al., 2013) and conversely enhances TRAF2 and TRAF6 degradation (Chung et al., 2013) . Despite the identification of these numerous immune regulatory proteins, a role of parkin in the modulation of immune function has not been extensively characterized (de Leseleuc et al., 2013; Manzanillo et al., 2013; Mira et al., 2004; Piquereau et al., 2013) . Our findings add additional information to support the role of parkin in immune modulation. Interestingly, as parkin has previously been shown to regulate the stability of TRAF2 (Chung et al., 2013) , and as TRAF2 and NOD2 are operational in the same inflammatory signaling pathway (Keestra-Gounder et al., 2016) , these data suggest that Parkin modulates multiple signaling intermediates via the control of protein stability in innate immune signal transduction.
In the coculture studies of primary astrocytes and SHSY5Y cells, the combined stressors of TG and LPS were required to demonstrate the astrocytic parkin effect on neurotropic function, whereas ER stress alone could elucidate this phenotype when primary astrocytes were cocultured with primary neurons. These data may reflect, in part, the stress resilience of the transformed SHSY5Y cells. However, the finding that ER stress alone could uncover this program in the primary cell cocultures concurrently supports that the NOD2 inflammatory regulatory program operates downstream of astrocytic ER stress, a concept that replicates this signaling sequence evident in bone marrow-derived macrophages (Keestra-Gounder et al., 2016) .
In contrast to the effects on ER stress and endotoxin stress, exposure to the traditional neurotoxic stressors linked to PD, 6-OHDA, and MPTP, resulted in a similar level of neuronal cell death when neurons were cocultured with astrocytes of either genotypes. These data support that the astrocyte specific role of parkin that is primarily involved in curbing ER stress to maintain neuronal integrity. These findings are consistent with the growing body of published data that points to an emerging role for glial cells implicated in many neurological disorders (Garden & Campbell, 2016; Jansen, Reits, & Hol, 2014; Liu, Teschemacher, & Kasparov, 2017) . Consistently, significant glial reactions have been reported in the postmortem PD brains (Banati, Daniel, & Blunt, 1998; Forno, DeLanney, Irwin, Di Monte, & Langston, 1992) . However, it is not clear if the defective glial function causes or results from PD pathology and additional investigations are needed to elucidate which aspect of glial dysfunction leads to reactive glial cell accumulation and neuronal death.
As more mechanistic details of the ER stress signaling emerge, cellular pathways connecting ER stress to mitochondria have been identified. Caspase-2, Bid and the thioredoxin-interacting protein play a critical role in relaying ER stress signaling to mitochondria with the subsequent induction of inflammation (Bronner et al., 2015; Oslowski et al., 2012) . Although parkin has been found to modulate mitochondrial homeostasis (Narendra, Walker, & Youle, 2012) and ER stress (Han et al., 2017) , as further evident in this study, whether parkin orchestrates the coordinate regulation of mitochondria and ER in astrocytes has not been explored. Parkin has also been found to modulate endolysosome mediated clearance of damaged mitochondria (Hammerling et al., 2017) and interestingly other PD associated mutations are linked to the disruption of endolysosome function (MacLeod et al., 2013) . Although parkin is now linked to mitochondrial function, ER stress and endo-lysosome functioning whether parkin plays a role in these integrated stress responses needs further validation. It is interesting to note the the combination of these three stress reponses have been identified in neurodegeneration linked to Alzheimer's disease (Umeda et al., 2011) .
Putting this together parkin may play a role in orchestrating multiple intracellular organelles, and stress signaling in conferring protection. Moreover, the demonstration that the restricted depletion of parkin in astrocytes exacerbates neuronal injury highlight that this E3
ligase may have both cell autonomous and paracrine effects on the overall health of dopaminergic neurons. The specific depletion of parkin in astrocytes in vivo is required to test these neurotropic effects of parkin in substantia nigra pars compacta dopaminergic neuronal homeostasis.
ACKNOWLEDGMENTS
MNS and HG were funded by the NHLBI Division of Intramural
Research and through the Michael J. Fox Foundation. We thank Dr
Gabriel Nunez from the University of Michigan, Ann Arbor, MI for the NOD2-HA pcDNA3 plasmid. pMD2.G and psPAX2 was a gift from Didier Trono from EPFL SV Global Health Institute, Switzerland.
ORCID
Michael N Sack https://orcid.org/0000-0002-3411-0000
